2006
DOI: 10.1016/j.chroma.2006.05.018
|View full text |Cite
|
Sign up to set email alerts
|

Use of liquid chromatography–mass spectrometry and a hydrolytic technique for the detection and structure elucidation of a novel synthetic vardenafil designer drug added illegally to a “natural” herbal dietary supplement

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
50
0

Year Published

2007
2007
2017
2017

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 88 publications
(51 citation statements)
references
References 14 publications
0
50
0
Order By: Relevance
“…The sildenafil product ion at m/z 377 results from fragmentation of the S-N sulfonamide bond with a hydrogen transfer, and the other sildenafil product ions listed in Table 1 are also devoid of the piperazine ring moiety [3,9,15,18]. Major product ions from compound 1 (thiosildenafil) are 30 Da higher than those seen in sildenafil (Table 1), 16 mass units attributed to the presence of a thioketone instead of a ketone and 14 mass units resulting from migration of the methyl group on the piperazine nitrogen atom to the thiocarbonyl sulfur atom, a phenomenon that has been previously reported [19].…”
Section: Cid-msmentioning
confidence: 99%
See 1 more Smart Citation
“…The sildenafil product ion at m/z 377 results from fragmentation of the S-N sulfonamide bond with a hydrogen transfer, and the other sildenafil product ions listed in Table 1 are also devoid of the piperazine ring moiety [3,9,15,18]. Major product ions from compound 1 (thiosildenafil) are 30 Da higher than those seen in sildenafil (Table 1), 16 mass units attributed to the presence of a thioketone instead of a ketone and 14 mass units resulting from migration of the methyl group on the piperazine nitrogen atom to the thiocarbonyl sulfur atom, a phenomenon that has been previously reported [19].…”
Section: Cid-msmentioning
confidence: 99%
“…Today, there are three such drugs approved by the U.S. Food and Drug Administration: sildenafil citrate (Viagra ® , manufactured by Pfizer), vardenafil hydrochloride (Levitra ® , manufactured by Bayer), and tadalafil (Cialis ® , manufactured by Lilly). In the last few years, these ED drugs and structurally modified synthetic analogues have been found in "natural" herbal health supplements marketed as aphrodisiacs [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17]. Most sildenafil analogues found as adulterants have been modified in the piperazine portion of the molecule, but recently, herbal dietary supplements were found to contain thiosildenafil [17] and thiohomosildenafil [16,17], two novel sildenafil analogues modified by replacing a carbonyl group in sildenafil with a thiocarbonyl group.…”
Section: Introductionmentioning
confidence: 99%
“…Thus far, a large number of analogues of sildenafil, tadarafil and vardenafil have been reported, [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23] while a new type of phosphodiesterase-5 (PDE-5) inhibitor, (R)-xanthoanthrafil, an anthranilic acid derivative, has been found in a dietary supplement advertising sexual enhancement for men. 24) (R)-Xanthoanthrafil was first synthesized as a candidate compound for the treatment of ED by Fujisawa Pharmaceutical Co., Ltd. (currently Astellas Pharma Inc., Tokyo, Japan), 25) and was reported as a PDE-5 inhibitor, FR226807, after the manufacturer discontinued the process of developing the drug for approval.…”
mentioning
confidence: 99%
“…This method was robust and rugged. The total validation was done as per ICH Q2(R1) guidelines and other useful guidelines 10,1,2,3,8,9,11,12 .…”
mentioning
confidence: 99%